<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Bramble: Medicines and Healthcare products Regulatory Agency</title>
    <link>https://news.ketelle.co.uk/entities/medicines-and-healthcare-products-regulatory-agency</link>
    <description>Stories involving Medicines and Healthcare products Regulatory Agency, told neutrally, with how each side covers them.</description>
    <language>en-gb</language>
    <atom:link href="https://news.ketelle.co.uk/entities/medicines-and-healthcare-products-regulatory-agency/feed.xml" rel="self" type="application/rss+xml"/>
    <item>
      <title>MHRA orders stronger antidepressant warnings on suicidal thoughts and lasting sexual side effects</title>
      <link>https://news.ketelle.co.uk/stories/mhra-confirms-change-affecting-people-in-uk-taking-antidepressants</link>
      <guid isPermaLink="true">https://news.ketelle.co.uk/stories/mhra-confirms-change-affecting-people-in-uk-taking-antidepressants</guid>
      <pubDate>Thu, 15 Oct 2026 17:41:14 +0100</pubDate>
      <category>Health</category>
      <description>The MHRA announced on 15 October that antidepressant leaflets will carry more prominent warnings about suicidal thoughts and behaviours, and will name Post SSRI Sexual Dysfunction for the first time. The regulator says the risks are not new and that patients should not stop their medicine without advice. (2 outlets: 1 left · 0 centre · 1 right)</description>
      <media:content url="https://i2-prod.mirror.co.uk/article37774941.ece/ALTERNATES/s1200d/0_embedded24204613.jpg" medium="image"/>
    </item>
  </channel>
</rss>
